ICYMI: A New Survey Seeks Answers About How COVID-19 is Impacting Rare Disease Patients in the United States
source: pixabay.com

ICYMI: A New Survey Seeks Answers About How COVID-19 is Impacting Rare Disease Patients in the United States

By Natalie Homan from In The Cloud Copy In the United States, a disease is considered “rare” if it affects less than 200,000 Americans at any given time. Diseases can…

Continue Reading ICYMI: A New Survey Seeks Answers About How COVID-19 is Impacting Rare Disease Patients in the United States
Controls Needed for the Dupuytren Biomarker Discovery Pilot Study
source: pixabay.com

Controls Needed for the Dupuytren Biomarker Discovery Pilot Study

We need controls! No, not cockpit controls or videogame controls, and no, we're not out of control. We need control participants for the Dupuytren Biomarker Discovery Pilot Study. Our goal is…

Continue Reading Controls Needed for the Dupuytren Biomarker Discovery Pilot Study
Treatment for HATTR Amyloidosis Polyneuropathy Approved for Reimbursement in Spain
source: pixabay.com

Treatment for HATTR Amyloidosis Polyneuropathy Approved for Reimbursement in Spain

According to a story from Guru Focus, the biopharmaceutical company Akcea Therapeutics, Inc., an affiliate of Ionis Pharmaceuticals, Inc. recently announced that the Ministry of Health of Spain has cleared…

Continue Reading Treatment for HATTR Amyloidosis Polyneuropathy Approved for Reimbursement in Spain
New Program Will Let Paramedics Visit Chronically Ill Patients Regularly in Their Homes, Reducing ER Visits
source: pixabay.com

New Program Will Let Paramedics Visit Chronically Ill Patients Regularly in Their Homes, Reducing ER Visits

Ocala Fire Rescue Department (OFD) has just launched a "community paramedicine program." The primary aim of this new program is to help keep patients who frequently call 911 out of…

Continue Reading New Program Will Let Paramedics Visit Chronically Ill Patients Regularly in Their Homes, Reducing ER Visits
First Ever Test Which can Predict Progression in Idiopathic Pulmonary Fibrosis is Making Progress
source: pixabay.com

First Ever Test Which can Predict Progression in Idiopathic Pulmonary Fibrosis is Making Progress

Idiopathic Pulmonary Fibrosis Progression Veracyte has just signed a deal with Yale University which will help them develop the very first test which can predict disease progression for idiopathic pulmonary…

Continue Reading First Ever Test Which can Predict Progression in Idiopathic Pulmonary Fibrosis is Making Progress
A Multiple Sclerosis Treatment May Aid SYT1-Associated Neurodevelopmental Disorder Patients Too!
source: pixabay.com

A Multiple Sclerosis Treatment May Aid SYT1-Associated Neurodevelopmental Disorder Patients Too!

Edwin Chapman, who works at the University of Wisconsin-Madison, has been studying neurons for most of his career. He and his team recently made a discovery regarding SYT1-associated neurodevelopmental disorder.…

Continue Reading A Multiple Sclerosis Treatment May Aid SYT1-Associated Neurodevelopmental Disorder Patients Too!
Company Raises $14 Million Towards Sanfilippo Syndrome and Other Rare Disease Research
source: pixabay.com

Company Raises $14 Million Towards Sanfilippo Syndrome and Other Rare Disease Research

According to a story from Sanfilippo News, the healthcare tech company RDMD has recently announced that it has raised $14 million in Series A financing that will be dedicated towards…

Continue Reading Company Raises $14 Million Towards Sanfilippo Syndrome and Other Rare Disease Research
Study: Treatment for Follicular Lymphoma Patients Must be Individualized
source: pixabay.com

Study: Treatment for Follicular Lymphoma Patients Must be Individualized

A recent study examined three different follicular lymphoma (FL) patients to try to better understand how the disease presents differently for different individuals. Ultimately, this study has reiterated the importance…

Continue Reading Study: Treatment for Follicular Lymphoma Patients Must be Individualized
Study Has Led to Better Understanding on the Difference Between Activated PI3K Delta Syndrome 1 and 2
source: pixabay.com

Study Has Led to Better Understanding on the Difference Between Activated PI3K Delta Syndrome 1 and 2

APDS Activated PI3K delta syndrome (APDS) is a form of primary immunodeficiency (PI). There are fewer than 100 reported cases of the condition. APDS has two types (1 and 2),…

Continue Reading Study Has Led to Better Understanding on the Difference Between Activated PI3K Delta Syndrome 1 and 2
Scientists Think They Have Found the First Pediatric COVID-19 Patient to Present with Kawasaki Disease
Sourced from Pixabay

Scientists Think They Have Found the First Pediatric COVID-19 Patient to Present with Kawasaki Disease

According to a story from abc7.com, a recent case study has identified what scientists believe to be the earliest case of a pediatric COVID-19 patient presenting with symptoms of pediatric…

Continue Reading Scientists Think They Have Found the First Pediatric COVID-19 Patient to Present with Kawasaki Disease